Loading...

⚠ โœ•
❮ Top
☎ Help
Draft upto 3 replies to a
tax notice โ€” FREE ๐ŸŽ‰ โœ•

150 credits ยท 30 days

โ€ข Basic Search โ†’ 1 Credit
โ€ข Advanced Search โ†’ 3 Credits
โ€ข Drafter โ†’ 20 to extract + 25 per issue
(โ‰ˆ upto 2-3 drafts on us)

Already used our earlier 20-Credit Demo?
You are still eligible for this new 150-Credit Demo.

Activate your FREE Demo โ†’
☰
×

By creating an account you can:

Logo TaxTMI
Call Us / Help / Feedbackโœ•

Contact Us At :

✉ E-mail: [email protected]

✆ Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters 0/2000
TMI Blog
Home / TMI Blogs / RSS

1996 (10) TMI 167

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....Sharma, JDR, for the Respondents. [Order per : Jyoti Balasundaram, Member (J)]. - The appellants have asked for a decision on merits. Hence we proceeded to hear the learned DR and considered the submissions contained in the appeal memorandum. The appellants herein are manufacturers of Fadomin tablets falling for classification under 3003.10. There is no dispute about the classification of th....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....r individually or in combination with other bulk drugs specified in the said Schedule excluding formulations based on tetracycline or hydrocortisone, for any therapeutic use other than for opthalmological use." The item in dispute is a formulation consisting of Pyrimathemine and sulpha-doxine. While pyrimathemine is a bulk drug specified in the Schedule to the Drugs (Prices) Control Order, 1987....